Cite
HARVARD Citation
Reilley, M. et al. (2019). TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma. Journal for immunotherapy of cancer. 7 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Reilley, M. et al. (2019). TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma. Journal for immunotherapy of cancer. 7 (1), p. . [Online].